AcelRx Pharmaceuticals Company Profile (NASDAQ:ACRX)

About AcelRx Pharmaceuticals

AcelRx Pharmaceuticals logoAcelRx Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company operates through the segment, which includes development and commercialization of product candidates for the treatment of pain. Its lead product candidates include ARX-04, Zalviso, which utilize sublingual sufentanil, delivered through a non-invasive route of administration, and ARX-03. ARX-04 is meant for the treatment of moderate-to-severe acute pain to be administered by a healthcare professional to a patient in medically supervised settings. Zalviso is meant for the management of moderate-to-severe acute pain in hospitalized adult patients. ARX-03 provides mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician's office. It also includes ARX-02, which is meant for the treatment of patients who suffer from breakthrough pain (BTP) due to cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ACRX
  • CUSIP:
Key Metrics:
  • Previous Close: $3.24
  • 50 Day Moving Average: $3.30
  • 200 Day Moving Average: $3.34
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.03
  • P/E Growth: 0.00
  • Market Cap: $146.81M
  • Outstanding Shares: 45,312,000
  • Beta: 2.24
Additional Links:
Companies Related to AcelRx Pharmaceuticals:

Analyst Ratings

Consensus Ratings for AcelRx Pharmaceuticals (NASDAQ:ACRX) (?)
Ratings Breakdown: 3 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.63)
Consensus Price Target: $7.30 (125.31% upside)

Analysts' Ratings History for AcelRx Pharmaceuticals (NASDAQ:ACRX)
Show:
DateFirmActionRatingPrice TargetDetails
8/16/2016RBC Capital MarketsReiterated RatingPositive$6.00View Rating Details
8/10/2016Jefferies GroupReiterated RatingBuyView Rating Details
8/5/2016Stifel NicolausDowngradeBuy -> HoldView Rating Details
8/1/2016HC WainwrightReiterated RatingBuyView Rating Details
7/29/2016Cowen and CompanyReiterated RatingHoldView Rating Details
5/6/2016Seaport Global SecuritiesUpgradeAccumulate -> BuyView Rating Details
4/14/2016Janney Montgomery ScottInitiated CoverageNeutralView Rating Details
3/8/2016Roth CapitalReiterated RatingBuyView Rating Details
10/30/2015Royal Bank Of CanadaLower Price Target$7.00 -> $6.00View Rating Details
5/6/2015MizuhoReiterated RatingNeutral$5.50 -> $3.00View Rating Details
3/10/2015JMP SecuritiesLower Price TargetMarket Outperform$12.00 -> $8.00View Rating Details
2/9/2015Canaccord GenuitySet Price TargetHold$8.00View Rating Details
(Data available from 8/26/2014 forward)

Earnings

Earnings History for AcelRx Pharmaceuticals (NASDAQ:ACRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/27/2016        
7/28/2016Q216($0.22)($0.24)$2.17 million$4.53 millionViewListenView Earnings Details
5/2/2016Q1($0.20)($0.24)$1.62 million$1.80 millionViewListenView Earnings Details
3/7/2016Q415($0.10)($0.24)$4.97 million$1.73 millionViewListenView Earnings Details
10/29/2015Q315($0.23)$0.11$1.75 million$13.90 millionViewListenView Earnings Details
8/3/2015Q215($0.26)($0.20)ViewListenView Earnings Details
5/4/2015Q115($0.28)($0.27)ViewN/AView Earnings Details
3/9/2015($0.33)($0.32)ViewN/AView Earnings Details
8/11/2014Q214($0.26)($0.24)$40.00 millionViewN/AView Earnings Details
5/8/2014Q114($0.23)($0.22)ViewN/AView Earnings Details
3/3/2014Q413($0.17)($0.18)$4.93 million$27.60 millionViewN/AView Earnings Details
11/5/2013Q313($0.19)($0.26)ViewN/AView Earnings Details
8/12/2013Q2 2013($0.22)($0.22)$1.73 million$0.41 millionViewListenView Earnings Details
11/6/2012Q312($0.38)($0.38)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for AcelRx Pharmaceuticals (NASDAQ:ACRX)
Current Year EPS Consensus Estimate: $-0.9 EPS
Next Year EPS Consensus Estimate: $-1.07 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.31)($0.19)($0.25)
Q2 20162($0.28)($0.23)($0.26)
Q3 20162($0.28)($0.22)($0.25)
Q4 20162($0.23)($0.23)($0.23)
Q1 20171($0.18)($0.18)($0.18)
Q2 20171($0.24)($0.24)($0.24)
Q3 20171($0.23)($0.23)($0.23)
Q4 20171($0.19)($0.19)($0.19)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for AcelRx Pharmaceuticals (NASDAQ:ACRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for AcelRx Pharmaceuticals (NASDAQ:ACRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/13/2016Howard B RosenCEOBuy10,206$3.26$33,271.56View SEC Filing  
5/12/2016Mark G EdwardsDirectorBuy15,000$3.15$47,250.00View SEC Filing  
11/18/2015Perceptive Advisors LlcMajor ShareholderSell176,200$5.35$942,670.00View SEC Filing  
11/6/2015Perceptive Advisors LlcMajor ShareholderSell92,100$4.59$422,739.00View SEC Filing  
9/9/2015Perceptive Advisors LlcMajor ShareholderSell310,000$4.18$1,295,800.00View SEC Filing  
5/7/2015Mark G EdwardsDirectorBuy40,000$3.13$125,200.00View SEC Filing  
3/10/2014Mark WanDirectorSell1,000,000$12.35$12,350,000.00View SEC Filing  
11/7/2013Perceptive Advisors Llcmajor shareholderBuy200,000$6.51$1,302,000.00View SEC Filing  
11/4/2013Perceptive Advisors Llcmajor shareholderBuy155,000$6.87$1,064,850.00View SEC Filing  
11/1/2013Perceptive Advisors LlcMajor ShareholderBuy360,660$6.91$2,492,160.60View SEC Filing  
9/20/2013Guy NohraDirectorSell158,153$10.59$1,674,840.27View SEC Filing  
9/18/2013Guy NohraDirectorSell128,780$10.42$1,341,887.60View SEC Filing  
7/23/2013Perceptive Advisors LlcMajor ShareholderBuy850,000$11.65$9,902,500.00View SEC Filing  
6/6/2013Mark G EdwardsDirectorBuy10,000$8.10$81,000.00View SEC Filing  
5/28/2013Adrian AdamsDirectorBuy75,000$8.19$614,250.00View SEC Filing  
12/7/2012Mark A WanDirectorBuy2,416,918$3.31$7,999,998.58View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for AcelRx Pharmaceuticals (NASDAQ:ACRX)
DateHeadline
investornewswire.com logoWill AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Hit $11.25 Price Target? - Investor Newswire (NASDAQ:ACRX)
www.investornewswire.com - August 19 at 8:20 PM
rttnews.com logoAUPH Loses Aura, PETX Scores Hat Trick, ACRX Meets Trial Goal (NASDAQ:ACRX)
www.rttnews.com - August 16 at 11:54 AM
feeds.benzinga.com logoAcelRx Pharmaceuticals' ARX-04 Final Stage Study Meets Primary Endpoint (NASDAQ:ACRX)
feeds.benzinga.com - August 15 at 10:37 AM
streetinsider.com logoAcelRx Pharma (ACRX) Says ARX-04 Phase 3 Met Primary Endpoint in Trauma/Injury Pain Reduction - StreetInsider.com (NASDAQ:ACRX)
www.streetinsider.com - August 15 at 10:32 AM
finance.yahoo.com logoAcelRx Pharmaceuticals' ARX-04 Phase 3 Trial Met its Primary Endpoint, Reduced Pain Intensity in ER Patients with Moderate-to-Severe Acute Pain (NASDAQ:ACRX)
finance.yahoo.com - August 15 at 10:32 AM
finance.yahoo.com logo7:01 am AcelRx reports the topline results from the Phase 3 SAP302 trial met its primary endpoint (NASDAQ:ACRX)
finance.yahoo.com - August 15 at 10:32 AM
biz.yahoo.com logoACELRX PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhib (NASDAQ:ACRX)
biz.yahoo.com - August 15 at 10:32 AM
capitalcube.com logoETF’s with exposure to AcelRx Pharmaceuticals, Inc. : August 8, 2016 (NASDAQ:ACRX)
www.capitalcube.com - August 8 at 3:18 PM
equities.com logoAcelRx Pharmaceuticals Inc. (ACRX) Drops 5.32% on August 04 ... - Equities.com (NASDAQ:ACRX)
www.equities.com - August 6 at 3:18 PM
investornewswire.com logoStrong Sell Calls For AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) At 0 - Investor Newswire (NASDAQ:ACRX)
www.investornewswire.com - August 5 at 8:42 PM
capitalcube.com logoAcelRx Pharmaceuticals, Inc. :ACRX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 (NASDAQ:ACRX)
www.capitalcube.com - August 5 at 3:16 PM
nasdaq.com logoAcelRx Pharmaceuticals (ACRX) in Focus: Stock Jumps 5.3% - Nasdaq (NASDAQ:ACRX)
www.nasdaq.com - August 4 at 3:18 PM
finance.yahoo.com logoACELRX PHARMACEUTICALS INC Financials (NASDAQ:ACRX)
finance.yahoo.com - August 4 at 3:18 PM
equities.com logoAcelRx Pharmaceuticals Inc. (ACRX) Jumps 5.32% on August 03 - Equities.com (NASDAQ:ACRX)
www.equities.com - August 4 at 11:48 AM
finance.yahoo.com logoAcelRx Pharmaceuticals (ACRX) in Focus: Stock Jumps 5.3% (NASDAQ:ACRX)
finance.yahoo.com - August 4 at 11:48 AM
finance.yahoo.com logoEdited Transcript of ACRX earnings conference call or presentation 28-Jul-16 8:30pm GMT (NASDAQ:ACRX)
finance.yahoo.com - August 2 at 8:02 AM
biz.yahoo.com logoACELRX PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:ACRX)
biz.yahoo.com - August 2 at 8:02 AM
fortune.com logoAnalyst Ratings Worth Watching: Iconix Brand Group Inc (NASDAQ ... - Review Fortune (NASDAQ:ACRX)
reviewfortune.com - August 1 at 3:16 PM
finance.yahoo.com logoAcelRx Pharmaceuticals to Present Initial Results of Phase 3 Study of ARX‑04 at World Congress of Mountain & Wilderness Medicine (NASDAQ:ACRX)
finance.yahoo.com - August 1 at 7:00 AM
equities.com logoAcelRx Pharmaceuticals Inc. (ACRX) Jumps 17.86% on July 29 - Equities.com (NASDAQ:ACRX)
www.equities.com - July 30 at 3:23 PM
investornewswire.com logoCan Shares Of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Hit $11.25? - Investor Newswire (NASDAQ:ACRX)
www.investornewswire.com - July 29 at 8:48 PM
biz.yahoo.com logoACELRX PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:ACRX)
biz.yahoo.com - July 29 at 6:13 AM
4-traders.com logoAcelRx Pharmaceuticals : Provides Corporate Update and Reports Second Quarter and Six Months 2016 Financial Results (NASDAQ:ACRX)
www.4-traders.com - July 28 at 9:30 PM
sg.finance.yahoo.com logoAcelRx Pharmaceuticals reports 2Q loss (NASDAQ:ACRX)
sg.finance.yahoo.com - July 28 at 6:17 PM
biz.yahoo.com logoQ2 2016 AcelRx Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:ACRX)
biz.yahoo.com - July 28 at 7:07 AM
finance.yahoo.com logoAcelRx Pharmaceuticals to Hold Second Quarter Financial Results Conference Call and Webcast on Thursday, … (NASDAQ:ACRX)
finance.yahoo.com - July 26 at 12:09 PM
finance.yahoo.com logoAcelRx Pharmaceuticals to Hold Second Quarter Financial Results Conference Call and Webcast on Thursday, July 28th, 2016 (NASDAQ:ACRX)
finance.yahoo.com - July 26 at 7:00 AM
investornewswire.com logoIs $11.25 Price Target Attainable For AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)? - Investor Newswire (NASDAQ:ACRX)
www.investornewswire.com - July 23 at 8:52 AM
News IconEquity Roundup: Stock Performance Focus on AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) - Press Telegraph (NASDAQ:ACRX)
presstelegraph.com - July 20 at 3:34 PM
investornewswire.com logoCan AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Keep Up with Analyst Expectations? - Investor Newswire (NASDAQ:ACRX)
www.investornewswire.com - July 20 at 3:34 PM
capitalcube.com logoETF’s with exposure to AcelRx Pharmaceuticals, Inc. : July 20, 2016 (NASDAQ:ACRX)
www.capitalcube.com - July 20 at 12:05 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) - TGP (NASDAQ:ACRX)
telanaganapress.com - July 19 at 9:29 AM
News IconAcelrx Pharmaceuticals Incorporated (NASDAQ:ACRX) Shorted Shares Increased By 30.92% - Press Telegraph (NASDAQ:ACRX)
presstelegraph.com - July 19 at 9:29 AM
news.cmlviz.com logoAcelRx Pharmaceuticals Inc Stock Momentum at Critical Inflection Point - CML News (NASDAQ:ACRX)
news.cmlviz.com - July 18 at 3:17 PM
News IconHow Analysts Rated AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) Last Week? - Press Telegraph (NASDAQ:ACRX)
presstelegraph.com - July 16 at 3:17 PM
News IconAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:ACRX)
www.engelwooddaily.com - July 14 at 3:17 PM
News IconInsiders Increasing Positions in: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) - Press Telegraph (NASDAQ:ACRX)
presstelegraph.com - July 14 at 12:09 PM
News IconAnalyst Target and Average Rating Watch: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) - Press Telegraph (NASDAQ:ACRX)
presstelegraph.com - July 14 at 12:09 PM
News IconAcelrx Pharmaceuticals Incorporated (NASDAQ:ACRX) Sellers Covered 2.85% of Their Shorts - Consumer Eagle (NASDAQ:ACRX)
www.consumereagle.com - July 13 at 3:19 PM
News IconIs Selling AcelRx Pharmaceuticals Inc Here a Winning Strategy? The Stock Formed Bearish Wedge Down - Consumer Eagle (NASDAQ:ACRX)
www.consumereagle.com - July 13 at 3:19 PM
News IconAcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:ACRX)
telanaganapress.com - July 12 at 8:45 PM
News IconShares Charging Upward in Session: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) - Telanagana Press (NASDAQ:ACRX)
telanaganapress.com - July 12 at 3:17 PM
fiscalstandard.com logoNext Weeks Broker Price Targets For AcelRx Pharmaceuticals, Inc. (ACRX) - Fiscal Standard (NASDAQ:ACRX)
www.fiscalstandard.com - July 10 at 8:04 AM
investornewswire.com logoIs $11.25 Within Reach For AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)? - Investor Newswire (NASDAQ:ACRX)
www.investornewswire.com - July 8 at 8:28 PM
News IconIncreased Volatility on Shares of: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) - Engelwood Daily (NASDAQ:ACRX)
www.engelwooddaily.com - July 8 at 3:18 PM
biz.yahoo.com logoACELRX PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:ACRX)
biz.yahoo.com - July 8 at 6:09 AM
News IconCompany Stock Focus for AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX): Which Way Will Shares Head? - Press Telegraph (NASDAQ:ACRX)
presstelegraph.com - July 7 at 11:12 AM
News IconIncreased Volatility Watch for: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) - Engelwood Daily (NASDAQ:ACRX)
www.engelwooddaily.com - July 6 at 3:17 PM
fiscalstandard.com logoBroker Outlook For AcelRx Pharmaceuticals, Inc. (ACRX) - Fiscal Standard (NASDAQ:ACRX)
www.fiscalstandard.com - July 6 at 8:03 AM
finance.yahoo.com logoAcelRx Pharmaceuticals to Present at Cantor Fitzgerald 2nd Annual Healthcare Conference (NASDAQ:ACRX)
finance.yahoo.com - July 6 at 7:00 AM

Social

AcelRx Pharmaceuticals (NASDAQ:ACRX) Chart for Friday, August, 26, 2016


Last Updated on 8/26/2016 by MarketBeat.com Staff